Conditions

Subcategories:Axial Spondyloarthritis Clinical Criteria/Guidelines Gout and Crystalline Arthritis Myositis Osteoarthritis and Bone Disorders Other Rheumatic Conditions Pain Syndromes Pediatric Conditions Psoriatic Arthritis Rheumatoid Arthritis Sjögren’s Disease Soft Tissue Pain Systemic Lupus Erythematosus Systemic Sclerosis Vasculitis

Updates on PsA: Insights into the Latest Psoriatic Arthritis Treatments & Research

Jason Liebowitz, MD, FACR | August 11, 2022

Ana-Maria Orbai, MD, MHS, addressed the latest research into psoriatic arthritis (PsA), including a comprehensive overview of the latest FDA-approved treatments and their implications for clinical practice.

A Clear Vision: Understanding the Connection Between Ophthalmology & Rheumatic Disease

Jason Liebowitz, MD, FACR | August 11, 2022

Meghan Berkenstock, MD, summarized key clinical pearls related to uveitis and rheumatic diseases during a session of the 18th Annual Advances in the Diagnosis & Treatment of the Rheumatic Diseases symposium.

COVID-19 Vaccinations in Immune-Compromised Patients

Arthritis & Rheumatology | July 27, 2022

A prospective observational study by Syversen et al. found that patients with immune-mediated inflammatory diseases (IMID) had an attenuated serologic response to the standard two-dose vaccine regimen but a third dose was safe and effective.

Clinical Challenges in SLE: Glucocorticoids—How Much Is Too Much?

Samantha C. Shapiro, MD | July 22, 2022

Glucocorticoids remain a prominent part of care for many patients with SLE but can have toxic side effects; this EULAR 2022 session discussed one institution’s approach to lower the dosage.

Refractory Gout Is a Myth: Tips from an Expert

Samantha C. Shapiro, MD | July 22, 2022

At this EULAR 2022 session, one expert explains why he believes refractory gout is caused by mismanagement and discussed ways around treatment obstacles.

Imaging Modalities in Gout: How to Use them in Clinical Practice

Samantha C. Shapiro, MD | July 21, 2022

This EULAR 2022 session discussed the increasing role of imaging in the diagnosis of gout.

Treating to Target in Gout: The Trouble with Serum Urate

Samantha C. Shapiro, MD | July 21, 2022

New analyses of treat to target in gout may lead to revisions in some guidelines.

Difficult-to-Treat Lupus: When & How to Use New Therapies

Samantha C. Shapiro, MD | July 21, 2022

Clinicians have numerous treatment options for SLE; in a EULAR 2022 session, some of the newer therapies were reviewed.

Phase 2 Study Shows Promising Results for Deucravacitinib in PsA

Michele B. Kaufman, PharmD, BCGP | July 19, 2022

Research has demonstrated that deucravacitinib is significantly more efficacious than placebo for achieving minimal disease activity in patients with active PsA after 16 weeks of treatment.

Baricitinib Promising for Juvenile Idiopathic Arthritis

Michele B. Kaufman, PharmD, BCGP | July 19, 2022

In a study from Ramanan et al., baricitinib proved safe and effective for reducing the time to flare and frequency of flare in patients aged 2–18 years with juvenile idiopathic arthritis.